Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2025-12-24 @ 5:55 PM
NCT ID:
NCT00313768
Eligibility Criteria:
Inclusion Criteria:
* Advanced Stage IIIb with pleural effusion or Stage IV nonsquamous non-small cell lung cancer
* ECOG Performance Status 0-1
* Measurable disease per RECIST criteria
Exclusion Criteria:
* Squamous cell, small cell, or carcinoid lung cancer
* CNS metastasis
* Pre-existing autoimmune or antibody mediated disease
* Prior systemic treatment for NSCLC with chemo, immunotherapy, biologics, or investigation drugs
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00313768
Study Brief:
Protocol Section:
NCT00313768